Filing Details

Accession Number:
0001127602-24-015363
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-15 07:04:53
Reporting Period:
2024-05-13
Accepted Time:
2024-05-15 07:04:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800110 K Charles Gayer 4505 Emperor Blvd.
Suite 200
Durham NC 27703
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-13 30,000 $5.47 307,533 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct